Long-term administration of citalopram reduces basal and stress-induced extracellular noradrenaline levels in rat brain

Psychopharmacology

Volumn 194, Issue 1, 2007, Pages 73-81

  Kawahara, Yukie ^a   Kawahara, Hiroshi ^b   Kaneko, Fumi ^a   Tanaka, Masatoshi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYUSHU DENTAL COLLEGE   (Japan)

Author keywords

Amygdala; Basolateral; Chronic treatment; Citalopram; Locus coeruleus; Microdialysis; Noradrenaline; Rat

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; CITALOPRAM; CLONIDINE; DESIPRAMINE; NORADRENALIN; NORADRENALIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIALYSATE LEVEL; LOCUS CERULEUS; LONG TERM CARE; MALE; MICRODIALYSIS; NONHUMAN; NORADRENALIN BRAIN LEVEL; NORADRENERGIC SYSTEM; PANIC; PRIORITY JOURNAL; RAT; STRESS;

ADRENERGIC ALPHA-AGONISTS; AMYGDALA; ANIMALS; AREA UNDER CURVE; BRAIN; CITALOPRAM; CLONIDINE; DIALYSIS SOLUTIONS; EXTRACELLULAR SPACE; INJECTIONS, SUBCUTANEOUS; LOCUS COERULEUS; MALE; MICRODIALYSIS; NOREPINEPHRINE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-2; SEROTONIN UPTAKE INHIBITORS; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 34548009344     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-007-0826-8     Document Type: Article

References (67)

1. Baba T, Takeda H, Lee JW, Takada K, Shibuya T (1995) Effect of fluvoxamine, a new antidepressant drug, on monoamine dynamics in the rat cerebral limbic system and its pharmacological characteristic. Nippon Yakurigaku Zasshi 105:177-185
2. Benmansour S, Altamirano AV, Jones DJ, Sanchez TA, Gould GG, Pardon MC, Morilak DA, Frazer A (2004) Regulation of the norepinephrine transporter by chronic administration of antidepressants. Biol Psychiatry 55:313-316
3. Boothman LJ, Mitchell SN, Sharp T (2006) Investigation of the SSRI augmentation properties of 5-HT(2) receptor antagonists using in vivo microdialysis. Neuropharmacology 50:726-732
4. 1A receptor-mediated feedback: a microdialysis study in the amygdala. J Neurochem 76:1645-1653
5. Boyer PA, Skolnick P, Fossom LH (1998) Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain. A quantitative in situ hybridization study. J Mol Neurosci 10:219-233
6. Brunello N, Blier P, Judd LL, Mendlewicz J, Nelson CJ, Souery D, Zohar J, Racagni G (2003) Noradrenaline in mood and anxiety disorders: basic and clinical studies. Int Clin Psychopharmacol 18:191-202
7. Coplan JD, Papp LA, Pine D, Martinez J, Cooper T, Rosenblum LA, Klein DF, Gorman JM (1997) Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder. Arch Gen Psychiatry 54:643-648
8. David DJ, Bourin M, Jego G, Przybylski C, Jolliet P, Gardier AM (2003) Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice. Br J Pharmacol 140:1128-1136
9. Debiec J, LeDoux JE (2006) Noradrenergic signaling in the amygdala contributes to the reconsolidation of fear memory: treatment implications for PTSD. Ann NY Acad Sci 1071:521-524
10. 2-adrenoreceptor activation inhibits LTP and LTD in the basolateral amygdala: involvement of Gi/o-protein-mediated modulation of Ca2+-channels and inwardly rectifying K+-channels in LTD. Eur J Neurosci 17:1411-1424
11. Fallon JH (1981) Histochemical characterization of dopaminergic, noradrenergic and serotonergic projections to the amygdala. In: Ben-Ari Y (ed) The amygdaloid complex. Elsevier, Amsterdam, pp 175-183
12. Fallon JH, Koziell DA, Moore RY (1978) Catecholamine innervation of the basal forebrain. II. Amygdala, suprarhinal cortex and entorhinal cortex. J Comp Neurol 180:509-532
13. Ferry B, Magistretti PJ, Pralong E (1997) Noradrenaline modulates glutamate-mediated neurotransmission in the rat basolateral amygdala in vitro. Eur J Neurosci 9:1356-1364
14. Ferry B, McGaugh JL (2000) Role of amygdala norepinephrine in mediating stress hormone regulation of memory storage. Acta Pharmacol Sin 21:481-493
15. Fernandez-Pastor B, Mateo Y, Gomez-Urquijo S, Javier Meana J (2005) Characterization of noradrenaline release in the locus coeruleus of freely moving awake rats by in vivo microdialysis. Psychopharmacology (Berl) 180:570-579
16. Fredricson Overo K (1982) Kinetics of citalopram in test animals; drug exposure in safety studies. Prog Neuropsychopharmacol Biol Psychiatry 6:297-309
17. Gorman JM, Kent JM, Sullivan GM, Coplan JD (2000) Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry 157:493-505
18. Gould GG, Altamirano AV, Javors MA, Frazer A (2006) A comparison of the chronic treatment effects of venlafaxine and other antidepressants on serotonin and norepinephrine transporters. Biol Psychiatry 59:408-414
19. Gracy KN, Pickel VM (1995) Comparative ultrastructural localization of the NMDAR1 glutamate receptor in the rat basolateral amygdala and bed nucleus of the stria terminalis. J Comp Neurol 362:71-85
20. Grant MM, Weiss JM (2001) Effects of chronic antidepressant drug administration and electroconvulsive shock on locus coeruleus electrophysiologic activity. Biol Psychiatry 49:117-129
21. Haddjeri N, de Montigny C, Blier P (1997) Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxtryptamine system. Br J Pharmacol 120:865-875
22. Halgren E (1982) Mental phenomena induced by stimulation in the limbic system. Hum Neurobiol 1:251-260
23. Harmer CJ, Mackay CE, Reid CB, Cowen PJ, Goodwin GM (2006) Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol Psychiatry 59:816-820
24. Huang M, Ichiwaka J, Li Z, Dai J, Meltzer HY (2006) Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex. Psychopharmacology (Berl) 185:274-281
25. Inoue T, Li XB, Abekawa T, Kitaichi Y, Izumi T, Nakagawa S, Koyama T (2004) Selective serotonin reuptake inhibitor reduces conditioned fear through its effect in the amygdala. Eur J Pharmacol 497:311-316
26. 2-adrenoceptors in antidepressant action: recent findings from microdialysis studies. Prog Neuropsychopharmacol Biol Psychiatry 28:819-827
27. Izumi T, Inoue T, Kitaichi Y, Nakagawa S, Koyama T (2006) Target brain sites of the anxiolytic effect of citalopram, a selective serotonin reuptake inhibitor. Eur J Pharmacol 534:129-132
28. Jongsma ME, Bosker FJ, Cremers TI, Westerink BH, den Boer JA (2005) The effect of chronic selective serotonin reuptake inhibitor treatment on serotonin 1B receptor sensitivity and HPA axis activity. Prog Neuropsychopharmacol Biol Psychiatry 29:738-744
29. Kawahara Y, Kawahara H, Westerink BH (1999) Comparison of effects of hypotension and handling stress on the release of noradrenaline and dopamine in the locus coeruleus and medial prefrontal cortex of the rat. Naunyn Schmiedebergs Arch Pharmacol 360:42-49
30. Kung MP, Choi SR, Hou C, Zhuang ZP, Foulon C, Kung HF (2004) Selective binding of 2-[125I]iodo-nisoxetine to norepinephrine transporters in the brain. Nucl Med Biol 31:533-541
31. Laakso A, Palvimaki EP, Kuoppamaki M, Syvalahti E, Hietala J (1996) Chronic citalopram and fluoxetine treatments upregulate 5-HT2c receptors in the rat choroid plexus. Neuropsychopharmacology 15:143-151
32. 2-adrenoceptors regulating noradrenergic transmission in the rat brain: a dual-probe microdialysis study. Br J Pharmacol 133:1362-1370
33. McGaugh JL (2004) The amygdala modulates the consolidation of memories of emotionally arousing experiences. Annu Rev Neurosci 27:1-28
34. McKittrick CR, Abercrombie ED (2007) Catecholamine mapping within nucleus accumbens: differences in basal and amphetamine-stimulated efflux of norepinephrine and dopamine in shell and core. J Neurochem 100:1247-1256
35. Millan MJ, Gobert A, Lejeune F, Newman-Tancredi A, Rivet JM, Auclair A, Peglion JL (2001) S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. J Pharmacol Exp Ther 298:565-580
36. 2-adrenergic and serotonin2C receptors: a comparison with citalopram. Eur J Neurosci 12:1079-1095
37. Morris JS, Ohman A, Dolan RJ (1999) A subcortical pathway to the right amygdala mediating "unseen" fear. Proc Natl Acad Sci USA 96:1680-1685
38. Murphy TK, Bengtson MA, Tan JY, Carbonell E, Levin GM (2000) Selective serotonin reuptake inhibitors in the treatment of paediatric anxiety disorders: a review. Int Clin Psychopharmacol 2:S47-S63
39. Neophytou SI, Aspley S, Butler S, Beckett S, Marsden CA (2001) Effects of lesioning noradrenergic neurones in the locus coeruleus on conditioned and unconditioned aversive behaviour in the rat. Prog Neuropsychopharmacol Biol Psychiatry 25:1307-1321
40. 2-adrenoceptor sensitivity in panic disorder. Arch Gen Psychiatry 46:165-169
41. Owens MJ, Morgan WN, Plott SJ, Nemeroff CB (1997) Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther 283:1305-1322
42. Page ME, Abercrombie ED (1997) An analysis of the effects of acute and chronic fluoxetine on extracellular norepinephrine in the rat hippocampus during stress. Neuropsychopharmacology 16:419-425
43. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic, Sydney
44. Pollock BG (2001) Citalopram: a comprehensive review. Expert Opin Pharmacother 2:681-698
45. Pudovkina OL, Kawahara Y, de Vries J, Westerink BH (2001) The release of noradrenaline in the locus coeruleus and prefrontal cortex studied with dual-probe microdialysis. Brain Res 906:38-45
46. Rainnie DG (1999) Serotonergic modulation of neurotransmission in the rat basolateral amygdala. J Neurophysiol 82:69-85
47. Ressler KJ, Nemeroff CB (2001) Role of norepinephrine in the pathophysiology of neuropsychiatric disorders. CNS Spectr 6:663-666
48. Robin AL, Burnstein Y (1998) Selectivity of site of action and systemic effects of topical alpha agonists. Curr Opin Ophthalmol 9:30-33
49. Rosenkranz JA, Grace AA (2001) Dopamine attenuates prefrontal cortical suppression of sensory inputs to the basolateral amygdala of rats. J Neurosci 21:4090-4103
50. Seedat S, van Rheede van Oudtshoorn E, Muller JE, Mohr N, Stein DJ (2003) Reboxetine and citalopram in panic disorder: a single-blind, cross-over, flexible-dose pilot study. Int Clin Psychopharmacol 18:279-284
51. Segal M (1979) Serotonergic innervation of the locus coeruleus from the dorsal raphe and its action on responses to noxious stimuli. J Physiol 286:401-415
52. 2- adrenergic receptor subtype gene expression in rat brain. Brain Res Mol Brain Res 21:133-149
53. Shekhar A, Sajdyk TJ, Gehlert DR, Rainnie DG (2003) The amygdala, panic disorder, and cardiovascular responses. Ann NY Acad Sci 985:308-325
54. Shiekhattar R, Aston-Jones G (1993) Sensory responsiveness of brain noradrenergic neurons is modulated by endogenous brain serotonin. Brain Res 623:72-76
55. Sodero AO, Valdomero A, Cuadra GR, Ramirez OA, Orsingher OA (2004) Locus coeruleus activity in perinatally protein-deprived rats: effects of fluoxetine administration. Eur J Pharmacol 503:35-42
56. Sullivan GM, Coplan JD, Kent JM, Gorman JM (1999) The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias. Biol Psychiatry 46:1205-1218
57. Svensson TH (2000) Brain noradrenaline and the mechanisms of action of antidepressant drugs. Acta Psychiatr Scand Suppl 402:18-27
58. Szabo ST, de Montigny C, Blier P (1999) Modulation of noradrenergic neuronal firing by selective serotonin reuptake blockers. Br J Pharmacol 126:568-571
59. Szabo ST, de Montigny C, Blier P (2000) Progressive attenuation of the firing activity of locus coeruleus noradrenergic neurons by sustained administration of selective serotonin reuptake inhibitors. Int J Neuropsychopharmacol 3:1-11
60. Tanaka M, Yoshida M, Emoto H, Ishii H (2000) Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety: basic studies. Eur J Pharmacol 405:397-406
61. Thomas DN, Nutt DJ, Holman RB (1998) Sertraline, a selective serotonin reuptake inhibitor modulates extracellular noradrenaline in the rat frontal cortex. J Psychopharmacol 12:366-370
62. Tukel R, Bozkurt O, Polat A, Genc A, Atli H (2006) Clinical predictors of response to pharmacotherapy with selective serotonin reuptake inhibitors in obsessive-compulsive disorder. Psychiatry Clin Neurosci 60:404-409
63. Uehara T, Sumiyoshi T, Matsuoka T, Tanaka K, Tsunoda M, Itoh H, Kurachi M (2005) Enhancement of lactate metabolism in the basolateral amygdala by physical and psychological stress: role of benzodiazepine receptors. Brain Res 1065:86-91
64. Valentini V, Cacciapaglia F, Frau R, Di Chiara G (2005) Selective serotonin reuptake blockade increases extracellular dopamine in noradrenaline-rich isocortical but not prefrontal areas: dependence on serotonin-1A receptors and independence from noradrenergic innervation. J Neurochem 93:371-382
65. Valentino RJ, Curtis AL, Parris DG, Wehby RG (1990) Antidepressant actions on brain noradrenergic neurons. J Pharmacol Exp Ther 253:833-840
66. Vermetten E, Bremner JD (2002) Circuits and systems in stress. I. Preclinical studies. Depress Anxiety 15:126-147
67. Wade AG (1999) Antidepressants in panic disorder. Int Clin Psychopharmacol 14(Suppl 2):S13-S17